Exploring regulatory data sets of the Comirnaty vaccine - First part
A summary of posts
We have come to an end (for now) of our exploration of the regulatory data available at the time of licensing the vaccine at the end of 2020 and, in a few cases, afterwards. As we covered a lot of ground, we summarise the posts and their content in one-liners in several “posts of posts” to allow readers to get to the bottom line.
The first three posts we…